Conditions: Healthy
Allocation: RANDOMIZED | Intervention model: CROSSOVER
Enrollment: 61
Healthy volunteers: yes

Brief summary:
The objectives of this study are to investigate the pharmacokinetics and safety of MT-6548 co-administered with iron supplements in healthy male volunteers.

Detailed description:

Arms:
arm 1: Subject will receive MT-6548 on Day 1, 4, and 7. Subject will receive Iron supplement A on Day 1, 4, or 7. Subject will receive Iron supplement B on Day 1, 4, or 7. arm 2: Subject will receive MT-6548 on Day 1 and 4. Subject will receive Iron supplement C on Day 1 or 4. arm 3: Subject will receive MT-6548 on Day 1 and 4. Subject will receive Iron supplement D on Day 1 or 4.

Interventions: intervention 1: MT-6548 intervention 2: Iron supplement A intervention 3: Iron supplement B intervention 4: Iron supplement C intervention 5: Iron supplement D
Intervention descriptions: intervention 1: Oral tablet intervention 2: Oral tablet intervention 3: Oral tablet intervention 4: Oral tablet intervention 5: Oral tablet

Protocol document:
Prot_000.pdf: 



























































































































































SAP_001.pdf: